Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

ABSTRACT:

Background

Chronic immune thrombocytopenia (ITP) is a debilitating autoimmune disorder that causes a reduction in blood platelets and increased risk of bleeding. ITP is currently managed with various pharmacologic therapies and splenectomy.This study was conducted to assess patient perceived and reported treatment side effects, as well as the perceived burden or bother, and need to reduce or stop treatment, associated with these side effects among adult patients with chronic ITP.

Methods

A Web-enabled survey was administered to members of a US-based ITP patient support group. Patients reported demographic and clinical characteristics, ITP treatments' side effects for treatments received since diagnosed, level of bother (or distress), and need to reduce or stop treatment, ass

SUBMITTER: Brown TM 

PROVIDER: S-EPMC3350461 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature